SAN DIEGO, Nov. 1, 2017 /PRNewswire/ — Medical Marijuana, Inc.(OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that it will be launching Subscribe & Save programs for the following brands: Real Scientific Hemp Oil; Dixie Botanicals; and all Cibaderm products.
The Subscribe & Save program allows customers to receive automatic shipments of their favorite Medical Marijuana, Inc. products at a discount of 20% each month. This newly announced program, gives customers total control with options to cancel, pause, or adjust their order at any time. Customers receive all of the benefits without any hassle.
“We know that many of our customers rely on our CBD products every single day, and have for months or years,” said Medical Marijuana, Inc. CEO Dr. Titus. “With that in mind, we’re glad to bring them and all our customers a more convenient experience with this program, as well as a considerable discount.”
Those interested in saving 20% on their quality CBD lifestyle products are encouraged to enroll this week in order to receive a free Real Scientific Hemp Oil Salve (a $34 value).
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s video statement, click here.
Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMER AND DISCLOSURES
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.
The statements in this press release have not been evaluated by the Food and Drug Administration (FDA) and are not intended to diagnose, treat or cure any disease. The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.
Public Relations Contact:
Chief Executive Officer
P: 888-829- 0070